Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2964)
All Articles published online
|
Mar 14, 2006 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kamenz T, Caca K, Blüthner T, Tannapfel A, Mössner J, Wiedmann M. Expression of c-kit receptor in human cholangiocarcinoma and in vivo treatment with imatinib mesilate in chimeric mice. World J Gastroenterol 2006; 12(10): 1583-1590 [PMID: 16570351 DOI: 10.3748/wjg.v12.i10.1583] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i10/1583.htm |
| Number | Citing Articles |
| 1 |
Christian D. Fingas, Joachim C. Mertens, Nataliya Razumilava, Steven F. Bronk, Alphonse E. Sirica, Gregory J. Gores. Targeting PDGFR‐β in Cholangiocarcinoma. Liver International 2012; 32(3): 400 doi: 10.1111/j.1478-3231.2011.02687.x
|
| 2 |
Atsushi Maeda, Sho Goto, Ryota Iwasaki, Koji Yamada, Mami Murakami, Hiroki Sakai, Takashi Mori. Outcome of Localized Bile Duct Carcinoma in Six Dogs Treated with Liver Lobectomy. Journal of the American Animal Hospital Association 2022; 58(4): 189 doi: 10.5326/JAAHA-MS-7199
|
| 3 |
Wen-Ling Kuo, Ming-Chin Yu, Ju-Fang Lee, Chi-Neu Tsai, Tse-Ching Chen, Miin-Fu Chen. Imatinib Mesylate Improves Liver Regeneration and Attenuates Liver Fibrogenesis in CCL4-Treated Mice. Journal of Gastrointestinal Surgery 2012; 16(2): 361 doi: 10.1007/s11605-011-1764-7
|
| 4 |
Marcus Wiedmann, Jürgen Feisthammel, Thilo Blüthner, Andrea Tannapfel, Thomas Kamenz, Annett Kluge, Joachim Mössner, Karel Caca. Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib. Anti-Cancer Drugs 2006; 17(7): 783 doi: 10.1097/01.cad.0000217433.48870.37
|
| 5 |
Luca Fabris, Massimiliano Cadamuro, Lidia Moserle, James Dziura, Xiangyu Cong, Luisa Sambado, Giorgia Nardo, Aurelio Sonzogni, Michele Colledan, Alberto Furlanetto, Nicolò Bassi, Marco Massani, Umberto Cillo, Claudia Mescoli, Stefano Indraccolo, Massimo Rugge, Lajos Okolicsanyi, Mario Strazzabosco. Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization. Hepatology 2011; 54(3): 890 doi: 10.1002/hep.24466
|
| 6 |
Jan-Hendrik Egberts, Bodo Schniewind, Clemens Schafmayer, Marie-Luise Kruse, Bence Sipos, Fred Fändrich, Holger Kalthoff, Jürgen Tepel. Establishment of a novel orthotopic xenograft model of human gallbladder carcinoma. Clinical & Experimental Metastasis 2007; 24(3): 141 doi: 10.1007/s10585-007-9058-x
|
| 7 |
Jürgen Feisthammel, Konrad Schoppmeyer, Joachim Mössner, Manfred Schulze, Karel Caca, Marcus Wiedmann. Irinotecan With 5-FU/FA in Advanced Biliary Tract Adenocarcinomas. American Journal of Clinical Oncology 2007; 30(3): 319 doi: 10.1097/01.coc.0000258124.72884.7a
|
| 8 |
Marcus Wiedmann, Helmut Witzigmann, Joachim Mössner. Clinical Hepatology. 2010; : 1519 doi: 10.1007/978-3-642-04519-6_62
|
| 9 |
Florian Eckel, Roland M Schmid. Emerging drugs for biliary cancer. Expert Opinion on Emerging Drugs 2007; 12(4): 571 doi: 10.1517/14728214.12.4.571
|
| 10 |
Federico Moriconi, Pierluigi Ramadori, Frank C. Schultze, Martina Blaschke, Ahmad Amanzada, Sajjad Khan, Giuliano Ramadori. Characterization of the erythropoietin/erythropoietin receptor axis in a rat model of liver damage and cholangiocarcinoma development. Histochemistry and Cell Biology 2013; 139(3): 473 doi: 10.1007/s00418-012-1037-x
|
| 11 |
Faezeh Hosseinzadeh, Jafar Ai, Abbas Hajifathali, Samad Muhammadnejad, Somayeh Ebrahimi-Barough, Iman Seyhoun, Tahereh Komeili Movahed, Sadegh Shirian, Fatemeh Hosseinzadeh, Sajjad Ahmadpour, Mohammadreza Alijani, Javad Verdi. The effects of Sorafenib and Natural killer cell co-injection in combinational treatment of hepatocellular carcinoma; an in vivo approach. Pharmacological Reports 2022; 74(2): 379 doi: 10.1007/s43440-021-00335-y
|